BioSpace News Archive

Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that its leadership will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22, 2020. The Company will present its corporate overview for fiscal year 2021 with a special focus on multiple growth opportunities driven by advances in the science of cell

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that it has received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial evaluating ADX-629, a novel orally available reactive aldehyde species (RASP) inhibitor, for the treatment of adult patients hospitalized for COVID-19. “The FDA’s clearance of our Investigational New Drug application

Yulong Eco-Materials Limited (OTC PINK:YECO ) today announced that it intends to build an incubator laboratory for development of cell and extracellular vesicle (EV) based therapeutics.

Partnerships will help advance the Lung Association’s COVID-19 Action Initiative to Support Communities Hit Hardest

CANbridge Pharmaceuticals Receives Chinese Marketing Approval for Hunterase ® First Enzyme Replacement Therapy for Hunter Syndrome in China BEIJING & CAMBRIDGE, Mass.--( BUSINESS WIRE )-- CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it received marketing approval from China’s National Medical Products Administration (NMPA) for Hunterase ® (I

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will participate in the virtual H.C. Wainwright 22nd Annual Global Investment Conference

CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix management will present a corporate overview at the virtual H.C. Wainwright 22 nd Annual Global Investment Conference taking place on September 14 – 16, 2020. H.C. Wainwright 22 nd Annual

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, Steven Lo, will present a company overview at the Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 10:40 am ET. A live webcast of the event will be available on the company’s website at http://ir.zosanopharma.com/events-presentations . The archived webcast will r

Experion Holdings Ltd.announced today that CEO, Mr. Jarrett Malnarich will present live at VirtualInvestorConferences.com on September 10 at 4:00 PM EDT / 1:00 PM PDT.

Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being